filmov
tv
Case 1: Bevacizumab in Stage IV Ovarian Cancer
Показать описание
Considerations for incorporating bevacizumab into one’s treatment for metastatic ovarian cancer.
0:05:11
Case 1: Bevacizumab in Stage IV Ovarian Cancer
0:54:29
3/26/2021: Upfront Treatment of Advanced Ovarian Cancer; Ay, Now the Plot Thickens
0:04:54
Case 1: BRAF-Mutated Metastatic Colorectal Cancer
0:01:13
Final OS results from PAOLA-1 evaluating 1L maintenance olaparib plus bevacizumab
0:03:46
What is the Role of Bevacizumab in Stage IV NSCLC?
0:05:45
Case 1: Considerations for Debulking Surgery
0:00:47
Bevacizumab for the treatment of patients with ovarian cancer exhibiting poor chemosensitivity
0:04:25
Adjuvant Chemotherapy + Bevacizumab for Ovarian Cancer
0:03:51
Chemotherapy in Early-Stage Ovarian Cancer
0:57:47
The effectiveness of bevacizumab (Avastin) and related trials
0:29:21
Advances in the Management of Cervical and Endometrial carcinoma
0:06:26
Presentation of Stage IIIc Ovarian Cancer
0:01:59
Ovarian Cancer Subtypes May Predict Response to Bevacizumab
0:31:55
Case Study: Stage IV Recurrent Ovarian Cancer Treatment
0:01:34
How long does it take to recover after Cancer treatment
0:03:42
PARP + Maintenance Bevacizumab in Ovarian Cancer
0:02:26
Understanding Brain Tumor Survival Rates
0:23:15
Is It Time to Change Upfront Chemotherapy for Ovarian Cancer?
0:58:25
Molecular Targeted Therapies for Advanced HCC
0:08:15
Bevacizumab in Ovarian Cancer
0:06:04
When to Add Bevacizumab for Recurrent Ovarian Cancer
0:26:02
Updates in Ovarian Cancer: Frontline Maintenance
0:06:38
A 68-Year-Old Woman With Stage IV Ovarian Cancer
0:04:54
Bevacizumab in Recurrent Ovarian Cancer
Комментарии